Stocklytics Platform
Asset logo for symbol BHC
Bausch Health Cos
BHC64
$6.45arrow_drop_up0.13%$0.00
Asset logo for symbol BHC
BHC64

$6.45

arrow_drop_up0.13%

Income Statement (BHC)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT$322.40M$400.91M$287.70M$497.90M$395.82M
EBITDA$647.00M$718.85M$606.27M$836.00M$693.00M
gross Profit$1.53B$1.41B$1.23B$4.22B$1.61B
NET Income-$85.00M$10.00M-$63.71M$395.00M-$378.00M
total Revenue$2.51B$2.40B$2.14B$2.40B$2.23B

Balance Sheet (BHC)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents----$760.00M
net Debt$20.78B$21.03B$21.29B$21.44B$21.67B
stockholders Equity-$1.17B-$1.17B-$1.11B-$1.02B-$1.18B
total Assets$26.54B$26.49B$26.88B$27.35B$27.06B
total Debt$21.50B$21.65B$22.05B$22.38B$22.43B
total Liabilities$26.78B$26.71B$27.05B$27.43B$27.29B

Cash Flow (BHC)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow-$189.00M-$423.36M-$334.49M-$79.00M$1.81B
free Cash Flow$341.84M$299.71M$123.44M$246.00M$236.00M
investing Cash Flow-----$1.99B
operating Cash Flow$411.18M$378.74M$206.07M$390.00M$282.00M

Bausch Health Cos (BHC) Financials

Bausch Health Cos Inc (BHC) is a global pharmaceutical company that develops and markets a wide range of healthcare products. The company's financials provide insights into its performance and financial health. The income statement shows the company's sales revenue, cost of goods sold, gross profit, operating expenses, and net income. Bausch Health Cos Inc had a total revenue of $8.6 billion in the last fiscal year, with a gross profit of $5.3 billion. The net income from stockholders was $1.1 billion.
The balance sheet reveals the company's assets, liabilities, and stockholders equity. Bausch Health Cos Inc has total assets worth $30.5 billion, with total debt of $24.9 billion. The stockholders equity stands at $1.8 billion. Cash equivalents, which include short-term investments, highly liquid assets, and treasury bills, are valued at $3.2 billion. Net debt, which refers to a company's total debt minus its cash and cash equivalents, is $21.7 billion.
In terms of cash flow, Bausch Health Cos Inc reports its operating, investing, and financing cash flows. The operating cash flow represents the cash generated from the company's primary operations. The investing cash flow shows the cash used for investments in assets or acquisitions. On the other hand, financing cash flow reflects the cash provided by or used for debt or equity financing activities. Bausch Health Cos Inc had a positive operating cash flow of $1.5 billion, investing cash flow of $43 million, and financing cash flow of $1.8 billion.
Free cash flow, an important measure of a company's financial performance, represents the cash flow from operations minus capital expenditures. Bausch Health Cos Inc generated $1.4 billion in free cash flow, indicating its ability to generate excess cash after meeting its capital requirements. This allows the company to invest in growth opportunities, pay dividends, or reduce debt. Overall, Bausch Health Cos Inc's financials demonstrate its strong revenue and profit generation, as well as its ability to manage its debts and generate positive cash flow.
add Bausch Health Cos  to watchlist

Keep an eye on Bausch Health Cos

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level